Driehaus Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Driehaus Capital Management’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-958,345	Closed	-$1.68M	–	485
2025 Q1	$1.68M	Buy	+958,345	New	+$1.26M	0.02%	328
2016 Q1	–	Sell	-780	Closed	-$817K	–	626
2015 Q4	$817K	Buy	+780	New	+$782K	0.03%	400
2015 Q2	–	Sell	-999	Closed	-$2.03M	–	572
2015 Q1	$2.03M	Buy	+999	New	+$2.17M	0.07%	331
2014 Q2	–	Sell	-210	Closed	-$227K	–	611
2014 Q1	$227K	Buy	+210	New	+$233K	0.01%	478

Other funds holding RGLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Driehaus Capital Management's RGLS Position: Q2 2025 in Review

Driehaus Capital Management sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 958,345 shares — an estimated $1.68M sold.

Driehaus Capital Management first reported a position in RGLS in Q1 2014 and held it in 4 quarters. The position peaked at $2.03M in Q1 2015. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

Driehaus Capital Management reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
Driehaus Capital Management sold 958,345 Regulus Therapeutics shares in Q2 2025, an estimated $1.68M.
Driehaus Capital Management first reported a position in Regulus Therapeutics in Q1 2014 and held it in 4 quarters.
Driehaus Capital Management's Regulus Therapeutics position peaked at $2.03M in Q1 2015.
0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Driehaus Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.